Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications
Frédéric Torossian, … , Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès
Frédéric Torossian, … , Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès
Published November 2, 2017
Citation Information: JCI Insight. 2017;2(21):e96034. https://doi.org/10.1172/jci.insight.96034.
View: Text | PDF
Research Article Bone biology Hematology

Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications

  • Text
  • PDF
Abstract

Neurogenic heterotopic ossification (NHO) is the formation of ectopic bone generally in muscles surrounding joints following spinal cord or brain injury. We investigated the mechanisms of NHO formation in 64 patients and a mouse model of spinal cord injury–induced NHO. We show that marrow from human NHOs contains hematopoietic stem cell (HSC) niches, in which mesenchymal stromal cells (MSCs) and endothelial cells provide an environment supporting HSC maintenance, proliferation, and differentiation. The transcriptomic signature of MSCs from NHOs shows a neuronal imprinting associated with a molecular network required for HSC support. We demonstrate that oncostatin M (OSM) produced by activated macrophages promotes osteoblastic differentiation and mineralization of human muscle-derived stromal cells surrounding NHOs. The key role of OSM was confirmed using an experimental model of NHO in mice defective for the OSM receptor (OSMR). Our results provide strong evidence that macrophages contribute to NHO formation through the osteogenic action of OSM on muscle cells within an inflammatory context and suggest that OSM/OSMR could be a suitable therapeutic target. Altogether, the evidence of HSCs in ectopic bones growing at the expense of soft tissue in spinal cord/brain-injured patients indicates that inflammation and muscle contribute to HSC regulation by the brain-bone-blood triad.

Authors

Frédéric Torossian, Bernadette Guerton, Adrienne Anginot, Kylie A. Alexander, Christophe Desterke, Sabrina Soave, Hsu-Wen Tseng, Nassim Arouche, Laetitia Boutin, Irina Kulina, Marjorie Salga, Beulah Jose, Allison R. Pettit, Denis Clay, Nathalie Rochet, Erica Vlachos, Guillaume Genet, Charlotte Debaud, Philippe Denormandie, François Genet, Natalie A. Sims, Sébastien Banzet, Jean-Pierre Levesque, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès

×

Figure 5

Osteogenic potential of human NHO-MDSCs in response to proinflammatory stimuli.

Options: View larger image (or click on image) Download as PowerPoint
Osteogenic potential of human NHO-MDSCs in response to proinflammatory s...
(A) Neurogenic heterotopic ossification muscle-derived stromal cells (NHO-MDSCs) were isolated, cultured, and then subsequently induced to differentiate into 3 mesenchymal lineages using specific media. Differentiation into osteoblasts, adipocytes, and chondrocytes was evaluated by Alizarin Red S, Oil Red O, and Alcian blue staining, respectively. Original magnification, ×10. (B) NHO-MDSCs express classical mesenchymal markers, as shown by flow cytometry. (C) NHO-MDSCs were cultured in control medium (CT) or osteogenic medium alone (OB) or were supplemented with LPS (100 ng/ml) (OB + LPS) or TNF-α (100 ng/ml) (OB + TNF-α) for 3 weeks. Cells were then stained with Alizarin Red S. Calcium mineralization was quantified and expressed as mean ± SEM (n = 4). For statistical analysis, 1-way ANOVA followed by Dunnett’s post-hoc test were used (*P ≤ 0.05, between experimental conditions). (D) Runx2 and BSPII protein expression by Western blot of NHO-MDSC cell lysates with (OB) or without (control [CT]) osteoblastic differentiation medium (day 3 and day 21, respectively). Ratios correspond to RUNX2/actin or BSPII/actin.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts